– FDA Accepts New Drug Application for Opicapone, a Once-Daily, Oral, Catechol-O-Methyltransferase (COMT) Inhibitor, as Adjunctive Therapy to Levodopa/Carbidopa- Prescription Drug User Fee Act (PDUFA) Target Action Date Set for April 26, 2020- New D… […]
Facility to lead discovery of new preclinical applications, disease modeling techniques, and drug discovery opportunities utilizing StemoniX’s proprietary microOrgan® platforms
LA JOLLA, Calif., July 8, 2019 /PRNewswire/ — StemoniX, a biotech compan… […]
SAN DIEGO, June 11, 2019 /PRNewswire/ — nanoComposix, a nanotechnology development and contract manufacturing company, recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public He… […]
SAN DIEGO, May 9, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet pa… […]
New investors further fuel community-owned genomic and health data platform
SAN DIEGO, May 8, 2019 /PRNewswire/ — LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, today announced the close of $4.6 million in n… […]
Enables Expanded Access to the Company’s Portfolio of Tests
SAN DIEGO, April 23, 2019 /PRNewswire/ — Epic Sciences, Inc. announced today that it has received a CE mark for its Liquid Biopsy Test Collection Kit, allowing for sale and distribution of… […]
BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet
SAN DIEGO, March 20, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio co… […]
LA IVF adds fourth location in Southern California, bringing successful, customized fertility treatments to local and international patients
LOS ANGELES, March 18, 2019 /PRNewswire/ — LA IVF Clinic (LAIVF) opened doors to its fourth clinic in March,… […]
SAN DIEGO, March 12, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymph… […]
$55 million equity financing from Athyrium and Secura Bio Executive Team$90 million debt financing with $50 million initial tranche funded immediately and additional $40 million of funding available
HENDERSON, Nev. and SAN DIEGO, March 5, 2019 /PRNew… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
